The Group’s 2022-2023 FY results have just been released. Driven by major advances in #oncology and a promising #RnD pipeline focused primarily on oncology and now #neurology, these #results serve to strengthen our transformation and fuel our #Servier2030 ambitions. 
Read the press release 👉#ServierResults #patient #strategy #WeAreServier #MovedByYou
#oncology #RnD #neurology #results #Servier2030